|
ANKRD13A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44649999999735E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48029999999622E-05 |
| Normal-vs-Stage2 |
4.889500E-02 |
| Normal-vs-Stage3 |
7.354300E-02 |
| Normal-vs-Stage4 |
9.344000E-01 |
| Stage1-vs-Stage2 |
3.770200E-01 |
| Stage1-vs-Stage3 |
2.868600E-01 |
| Stage1-vs-Stage4 |
5.382400E-02 |
| Stage2-vs-Stage3 |
9.588800E-01 |
| Stage2-vs-Stage4 |
1.924630E-01 |
| Stage3-vs-Stage4 |
2.351400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.417760E-04 |
| Normal-vs-AfricanAmerican |
2.08039999999299E-05 |
| Normal-vs-Asian |
9.812600E-01 |
| Caucasian-vs-AfricanAmerican |
1.077770E-01 |
| Caucasian-vs-Asian |
2.095000E-01 |
| AfricanAmerican-vs-Asian |
8.420100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55749999999999E-06 |
| Normal-vs-Female |
4.210400E-02 |
| Male-vs-Female |
8.002100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.067200E-01 |
| Normal-vs-Extreme_Weight |
6.407100E-04 |
| Normal-vs-Obese |
3.752800E-04 |
| Normal-vs-Extreme_Obese |
5.156000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.342760E-01 |
| Normal_Weight-vs-Obese |
6.569600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.023600E-01 |
| Extreme_Weight-vs-Obese |
5.698800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.311800E-01 |
| Obese-vs-Extreme_Obese |
1.716800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.815970E-02 |
| Normal-vs-Age(41-60Yrs) |
1.6069399999985E-05 |
| Normal-vs-Age(61-80Yrs) |
7.376100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.203200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.247800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.707400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.538200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.035360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.934210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.603400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.53800000407745E-08 |
| Normal-VS-Type2 PRCC |
5.657400E-01 |
| Normal-VS-KIRP CIMP |
1.787590E-02 |
| Normal-VS-Unclassified PRCC |
1.111690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.35109999965799E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.563000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.283600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.356410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.888400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.281200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.300000E-02 |
| Normal-vs-N1 |
1.886380E-01 |
| Normal-vs-N2 |
2.978600E-01 |
| N0-vs-N1 |
5.210200E-01 |
| N0-vs-N2 |
5.139500E-03 |
| N1-vs-N2 |
1.743820E-01 |
|
|
